Found 16 matching trials
A Randomized Phase I Study of a Hepatitis B Antigen Combined With IMP321 PHASE1 This is a single centre, three single administrations (Days 1, 29 and 57) a...
Show More Learn More & Join Trial
IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma PHASE1 Open label, non-randomized, fixed dose-escalation phase I study, performed ...
Show More Location
Hôpital Européen Georges Pompidou
Learn More & Join Trial
Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic Melanoma PHASE1 RATIONALE: Drugs used in chemotherapy, such as cyclophosphamide and fludara...
Show More Location
Centre Hospitalier Universitaire Vaudois
Learn More & Join Trial
Lag-3 and Gemcitabine for Treatment of Advanced Pancreas Cancer PHASE1 The overall purpose of this research is to evaluate the safety and toxicity...
Show More Location
Washington University
Learn More & Join Trial
Combination Study With Soluble LAG-3 Fusion Protein Eftilagimod Alpha (IMP321) and Pembrolizumab in Patients With Previously Untreated Unresectable or Metastatic NSCLC, or Recurrent PD-X Refractory NSCLC or With Recurrent or Metastatic HNSCC PHASE2 Evaluate the safety and efficacy of the combination of eftilagimod alpha wi...
Show More Location
Oncology Consultants
Learn More & Join Trial
Combination Study With Eftilagimod Alpha (a Soluble LAG-3 Fusion Protein) and Pembrolizumab in Patients With Recurrent or Metastatic HNSCC PHASE2 Evaluate the safety and efficacy of eftilagimod alpha in combination with p...
Show More Location
University of Alabama at Birmingham (UAB) - O'Neal Cancer Center
Learn More & Join Trial
A Study in Hormone Receptor-positive Metastatic Breast Carcinoma Patients to Test a New Schedule of Efti (IMP321, Eftilagimod Alpha) as Adjunctive to a Weekly Treatment Regimen of Paclitaxel PHASE1 This is a multicentre, multinational Phase Ib study in female HR+ MBC patie...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides PHASE1 Open-label single center study. Patients will be divided in four groups of ...
Show More Location
Cliniques Universitaires Saint-Luc
Learn More & Join Trial
Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination With Paclitaxel Chemotherapy PHASE2 The goal of this clinical trial is to compare the safety and efficacy of ef...
Show More Location
The Oncology Institute
Learn More & Join Trial
Phase I Study of IMP321 Given Alone or as an Adjuvant to a Reference Flu Antigen PHASE1 This study is a single centre, single blind, placebo (step 1) or reference ...
Show More Learn More & Join Trial